K. Ballantine

International incidence of childhood cancer, 2001–10: a population-based registry study

Eva Steliarova-Foucher, S Rohrmann, F Levi, 2017, The Lancet. Oncology.

Analysis of common cytogenetic abnormalities in New Zealand pediatric ALL shows ethnically diverse carriage of ETV6‐RUNX1, without a corresponding difference in survival

K. Ballantine, T. Pettit, S. Macfarlane, 2017, Pediatric blood & cancer.

Small Numbers, Big Challenges: Adolescent and Young Adult Cancer Incidence and Survival in New Zealand.

Ma Yi, M. Sullivan, K. Ballantine, 2017, Journal of adolescent and young adult oncology.

Listening to the experts: Parents' perspectives around infection risk and returning to education and social activities following their child's diagnosis of acute lymphoblastic leukemia

K. Ballantine, S. Macfarlane, Claire Gooder, 2021, Cancer reports.

Childhood cancer registration in New Zealand: A registry collaboration to assess and improve data quality.

K. Ballantine, S. Macfarlane, S. Hunter, 2018, Cancer epidemiology.

The burden of cancer in 25-29 year olds in New Zealand: a case for a wider adolescent and young adult age range?

M. Sullivan, K. Ballantine, Heidi Watson, 2018, The New Zealand medical journal.

An Age Stratified Analysis of the Access to Care Continuum Across Three Tumor Groups: Are There Delays for AYA?

K. Ballantine, T. Pettit, R. Spearing, 2019, Journal of adolescent and young adult oncology.

"I Don't Have to be Sick to Still Be Worthy": The Barriers Experienced by Adolescent and Young Adult Cancer Survivors in New Zealand.

K. Ballantine, T. Pettit, C. Hemmaway, 2022, Journal of adolescent and young adult oncology.